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Abstract
Objective: A major challenge in the care of preterm infants is the early identifi-
cation of compromised neurological development. While several measures are
routinely used to track anatomical growth, there is a striking lack of reliable
and objective tools for tracking maturation of early brain function; a corner-
stone of lifelong neurological health. We present a cot-side method for measur-
ing the functional maturity of the newborn brain based on routinely available
neurological monitoring with electroencephalography (EEG). Methods: We
used a dataset of 177 EEG recordings from 65 preterm infants to train a multi-
variable prediction of functional brain age (FBA) from EEG. The FBA was vali-
dated on an independent set of 99 EEG recordings from 42 preterm infants.
The difference between FBA and postmenstrual age (PMA) was evaluated as a
predictor for neurodevelopmental outcome. Results: The FBA correlated
strongly with the PMA of an infant, with a median prediction error of less than
1 week. Moreover, individual babies follow well-defined individual trajectories.
The accuracy of the FBA applied to the validation set was statistically equivalent
to the training set accuracy. In a subgroup of infants with repeated EEG record-
ings, a persistently negative predicted age difference was associated with poor
neurodevelopmental outcome. Interpretation: The FBA enables the tracking of
functional neurodevelopment in preterm infants. This establishes proof of prin-
ciple for growth charts for brain function, a new tool to assist clinical manage-
ment and identify infants who will benefit most from early intervention.
Introduction
Preterm birth is a substantial risk to infant health. While
mortality rates have dropped considerably over recent
years due to improvements in clinical care, these infants
remain at significant risk of neurodevelopmental delay
and a host of other chronic impairments in later life.1,2 It
is, therefore, of critical importance to reduce the exposure
of the preterm infant to neurological adversities while in
the neonatal intensive care unit (NICU), and to identify
those infants who will benefit most from early interven-
tion.3 Recent advances in neurological care have also
stressed the need for improving early functional biomark-
ers of neurodevelopment to expedite cycles within clinical
intervention trials.4
Monitoring physiological and anatomical growth is
crucial for clinicians when optimizing the care of very or
extremely preterm infants. Critical time periods for the
direction of care are usually the first days after birth, the
time of discharge from tertiary care to step-down units,
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as well as the follow-up visit at term-equivalent age. Elec-
troencephalography (EEG) is widely used for early thera-
peutic decisions and the prediction of
neurodevelopmental outcome in preterm infants.5,6
Assessing brain maturity via the visual interpretation of
the EEG during an infant’s stay in the NICU has been a
part of clinical practice for decades.7 Its use complements
traditional anatomical measures such as weight, length,
and head circumference. However, the clinical use of EEG
in the NICU is complicated by difficulties in interpreta-
tion and the availability of expertise to perform interpre-
tation.8 Computer-assisted analysis presents an
opportunity to solve both problems by providing simpli-
fied EEG measures that can be interpreted by clinical
staff, on demand and in real time.
The concept of brain age is one such measure than can
be automated.9 A lag between estimated functional brain
age (FBA) from the EEG and the postmenstrual age
(PMA) of the individual – the predicted age difference
(PAD) – holds potential as a functional biomarker for use
in neuro-intensive care. We have previously shown that it
is possible to construct computational measures that
emulate visually observed features of maturation10,11 and
correlate with pathological changes in neurological func-
tion.12,13 Recent advances in computational neuroscience
suggest that the EEG contains markers of brain function
that are not readily discernible by visual EEG review.14
Key information lies within the widespread network of
intermittent bursting that dominates early cortical activ-
ity.15 This developmentally unique activity is known to be
crucial for supporting neuronal growth and guiding early
brain wiring.16 It changes rapidly over the last trimester,
is sensitive to endogenous and exogenous disturbances,
and is predictive of future neurodevelopment.17-19 Here,
we incorporated novel measures of the EEG into an anal-
ysis of the functional maturity of the preterm brain. We
then determined the efficacy and validity of automated
EEG analysis as a reliable biomarker of the functional
maturity of the preterm brain and assessed its potential as
a predictor of neurodevelopmental outcome.
Materials and Methods
This study employed two different datasets of serial EEG
recordings of preterm infants recorded from NICUs in dif-
ferent countries. The first dataset (recorded in Vienna: 65
infants, 177 EEG recordings) was used to train and evaluate
the FBA measure, as well as investigate the use of FBA as a
predictor of neurodevelopmental outcome (Fig. 1). The
second dataset (recorded in Utrecht: 42 infants, 99 EEG
recordings) was used to validate the FBA measure trained
on the first dataset. Infants were born before 29 weeks ges-
tation, with EEG recorded serially at 25–39 weeks PMA
(Vienna) or 25–34 weeks PMA (Utrecht). We used
machine learning techniques to form an estimate of FBA
using quantitative EEG (qEEG) variables that can be
grouped into three categories: phenomenological analysis,
burst analysis, and other recently developed analyses
(Table S1 in the Supporting Information).
Data acquisition
The training dataset consisted of 67 preterm infants
admitted to the NICU at the Vienna General University
Hospital, Austria (see Table 1). Infants were included in
the study cohort if they were born before 29 weeks gesta-
tional age (GA), medically stable at the time of EEG
recordings, and parental consent was received. EEG was
acquired with nine scalp electrodes using a Brain Quick/
ICU EEG (MicroMed, Treviso, Italy) at a sampling fre-
quency of 256 Hz. Electrode positions reflect the 10-20
international system (modified for neonates) and were
located at Fp1, Fp2, C3, C4, T3, T4, O1, O2, with a refer-
ence at Cz. A bipolar montage (double banana) was used
in analysis: Fp1-C3, C3-O1, Fp1-T3, T3-O1, Fp2-C4, C4-
O2, Fp2-T4, T4-O2. The EEG was recorded as soon as
possible after birth and at fortnightly intervals until term
equivalent age, where possible. Comorbidities and medi-
cations at the time of recording are listed in Table 1.
Each EEG recording was split into 1 h epochs (with a
75% overlap). Epochs with excessive artefact were
excluded from further analysis (see Table 1). GA was
defined according to the last menstrual period (LMP). If
the LMP-based assessment of gestation deviated consider-
ably from ultrasound findings in the first trimester, ultra-
sound measurements were used as a surrogate measure of
LMP. PMA, defined as the sum of GA and postnatal age,
was used as the benchmark, true age of an infant.
The neurodevelopmental outcome of infants was
assessed at ages 1 year and 2 years (Bayley Scales of
Infant Neurodevelopment II and III — BII and BIII,
respectively; assessed against German norms). Of the 67
preterm infants initially included in the study, 2 were
assessed with BII at 1 year, 19 were assessed with BII at
2 years, 35 were assessed with BIII at 2 years, and 11
infants were not assessed for neurodevelopmental out-
come. Infants were stratified according to outcome using
the following rules applied to the latest available assess-
ment (either 1 year or 2 years): normal (mental develop-
mental index and physical developmental index greater
than 85 [scale II]; or cognitive index, language index, and
motor index greater than 85 [scale III]), or abnormal (ei-
ther mental developmental index or physical developmen-
tal index less than 70 [scale II]; or either cognitive index,
language index, or motor index less than 70 [scale III]).
Those infants with intermediate scores that did not fit
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into the normal or abnormal categories were categorized
as mildly abnormal.
A summary of the database before and after the rejec-
tion of epochs with an excessive amount of artefact is
presented in Table 1. Data collection was approved by the
local ethics committee and written, informed, parental
consent was received for each infant included in the data-
base (Medical University Vienna, Austria; study protocol
EK Nr 67/2008).
Data acquisition for independent, validation
dataset
We used an independent dataset to validate the multivari-
able models of age prediction. This validation dataset
contained EEG recordings from 43 neonates admitted to
the NICU at the Wilhelmina Children’s Hospital, Utrecht,
Netherlands. The data were collected as part of a multi-
center European study.21 Infants were included in this
Figure 1. Data acquisition, training, evaluation, and testing of the FBA. The histograms depict the distribution of EEG recordings with PMA (in
weeks) in each dataset. The bottom row illustrates the analyses corresponding to each dataset. PAD is the predicted age difference between
functional brain age (FBA) and post-menstrual age (PMA).
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study if they were born less than 28 weeks GA and
informed, written parental consent was received. Infants
were excluded if the presence of chromosomal or congen-
ital abnormalities were identified and if the neuro-moni-
toring was performed with devices other than the BrainZ
BRM3 monitor (Natus Medical Incorporated, Seattle,
USA). Long duration EEG recordings (~72 h) were
recorded as close as possible to admission, followed by
shorter recordings (~4–6 h) at weekly intervals (up to a
postatal age of approximately 4 weeks). EEG was recorded
with a BrainZ BRM3 monitor and needle electrodes at a
sampling frequency of 256 Hz. Two derivations were
recorded and used in the analysis: F4-P4 and F3-P3. All
neonates had a neurological examination and psychologi-
cal testing at 30 months of corrected age (Bayley Scales of
Infant and Toddler Development III; assessed against
Dutch norms). Neonates with normal neurodevelopmen-
tal outcome at this age were included in the validation
cohort (normal was defined as per the Vienna dataset;
n = 43 infants satisfied these criteria). The data collection
protocol was approved by the local medical ethics com-
mittee.
EEG preprocessing
EEG recorded in an intensive care environment is prone
to contamination from electrical activity that is not corti-
cal in origin. All data were filtered with a high pass filter
(Butterworth, 4th order, cutoff frequency at 0.5 Hz) and
then a low-pass filter (Butterworth, 6th order, cutoff fre-
quency at 16 Hz) to eliminate high frequency activity that
is more commonly associated with artefacts, including
muscle activity.8 EEG recordings were then segmented
into 1 h epochs. To account for further artefacts, yet
include as many 1 h EEG epochs as possible, we used
automated rejection of EEG epochs with excessive arte-
fact. We did not analyze epochs with considerable spatial
imbalance in amplitude (EEG derivations with a factor of
2 difference in mean amplitude from any other
Table 1. A summary of infants and EEG recordings before and after
application of artefact rejection.
Development: Vienna Initial
Post-artefact
rejection
gestational age (weeks) 25.3 (24.5–27.0) 25.3 (24.5–27.0)
birthweight (g) 707 (605–920) 704 (604–922)
sex (m:f)† 34:31 33:30
PMA of EEG recording
1st 27.0 (26.6–29.4;
n = 67)
27.9 (26.7–29.6;
n = 52)
2nd 30.8 (29.2–31.8;
n = 59)
31.0 (29.5–31.8;
n = 43)
3rd 33.7 (32.0–34.4;
n = 54)
33.6 (32.0–34.4;
n = 46)
4th 35.3 (33.1–36.4;
n = 37)
35.2 (34.1–36.0;
n = 36)
5th 36.5 (35.2–37.4;
n = 16)
36.4 (34.9–36.7;
n = 9)
6th 38.6 (n = 1) 38.6 (n = 1)
Intraventricular hemorrhage 14 (I/II = 10,
III/IV = 4)
14 (I/II = 10,
III/IV = 4)
Periventricular
leukomalacia
2 (I/II = 2) 1 (I/II = 1)
Necrotizing
enterocolitis
3 3
Chronic lung
disease
19 19
Patent ductus
arteriosus
49 48
Medications at EEG recording
No medication 15 (6%) 10 (6%)
Caffeine 195 (83%) 152 (86%)
Morphine 12 (5%) 10 (6%)
Inotropes 5 (2%) 5 (3%)
Doxapram 8 (3%) 5 (3%)
Anticonvulsants 2 (1%) 0 (0%)
Dexamethasone 1 (0.4%) 1 (0.6%)
Missing data 14 (6%) 9 (5%)
Infants Recordings 1 h epochs
Initial 67 234 1686
Post-artefact rejection 65 177 1137
Outcome
Normal 20 (100%) 57 (76%) 376 (65%)
Mildly abnormal 18 (95%) 57 (78%) 338 (73%)
Abnormal 16 (94%) 41 (75%) 238 (62%)
Unknown 11 (100%) 22 (71%) 185 (71%)
Validation: Utrecht Initial Post-artefact rejection
Gestational age (weeks) 26.9 (26.0–27.6) 26.9 (26.1–27.6)
Birthweight (g) 920 (830–1068) 920 (830–1070)
Sex (m:f) 27:16 26:16
Infants 43 42
Recordings 105 99
1 h epochs 6561 6101
For outcome, percentages refer to the number of infants/recordings/
1 h epochs that were in the initial set that passed the artefact rejec-
tion stage, for medications percentages are based on the number of
recordings in the initial and post-artefact rejection sets, respectively
and other values are presented as median (interquartile range). For
intraventricular hemorrhage and periventricular leukomalacia, roman
numerals indicate increasing grades of severity; assessed by cranial
ultrasound.20
†Data missing from two infants.
(Continued)
Table 1. Continued.
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derivation), persistent excessive amplitude (greater than
25% of the recording with burst amplitudes greater than
500 µV), or persistent low amplitude (greater than 50%
of the recording with EEG activity less than 5 µV).
Prediction of post-menstrual age using qEEG
Single and multivariable models of PMA were calculated
using regression analysis. These models used a combina-
tion of summary measures of the EEG (qEEG variables),
calculated on 1 h epochs, as an input and generated a
prediction of PMA as an output. The qEEG variables used
in this study can be grouped into three categories: phe-
nomenological analysis (m = 46), burst analysis (m = 40),
and other analysis paradigms (m = 10). Phenomenologi-
cal analysis extracts qEEG variables that mirror the visual
interpretation of the EEG.10,11 Burst analysis extracts
qEEG variables that identify important characteristics of
highly irregular (“crackling”) noise, through analysis of
EEG bursts.14 Other advanced analyses extract qEEG vari-
ables that represent complex characteristics of the preterm
EEG such as entropy, global connectivity, and cross-chan-
nel coupling.22-28
Leave-one-subject-out cross-validation was used when
generating models with a single or multivariable input
and FBA as output. In the case of N subjects (infants), a
training set consisting of the qEEG variables from N-1
subjects was used to train the regression model that out-
puts a FBA. The accuracy of the FBA was then calculated
using the left-out subject. The process was repeated until
all subjects had been left out, allowing accuracy to be esti-
mated on the entire cohort. Single and multivariable
model parameters were estimated using support vector
regression with a medium Gaussian kernel (a kernel scale
of 10, a box constraint equal to the interquartile range of
PMA/1.349 and epsilon equal to the box constraint/10).
Support vector regression is tolerant of redundant and
irrelevant variables; nonetheless, we implemented a pro-
cess of variable selection to rank the importance of each
qEEG variable to the determination of age and to reduce
the computational burden of the multivariable model.
Backwards selection was used (fourfold cross-validation
within the training set), with the mean square error
between FBA and PMA as a cost function to be mini-
mized.
Independent validation
A multivariable model was trained on all available data in
the Vienna dataset and then applied to the independent
dataset collected at the Wilhelmina Children’s Hospital,
Utrecht, Netherlands. The range of PMA and electrode
recording configurations were not identical between the
EEG recordings from Vienna and Utrecht. To overcome
this heterogeneity, the multivariable model was trained
on fronto-central derivations (Fp1-C3, Fp2-C4) in the
Vienna dataset and applied to the fronto-parietal deriva-
tions in the Utrecht dataset. This was one of the closest
approximations, in terms of position and distance
between electrodes, given the available configurations of
the Vienna dataset (we also tested centro-temporal deriva-
tions). Model efficacy was only compared across a similar
PMA range between the two datasets (24–33 weeks
PMA).
Statistical analysis
A prediction was made on a 1 h epoch of EEG; if multi-
ple EEG epochs exist per recording then the average pre-
dicted age per recording was used. The goodness-of-fit
between predicted age (single and multivariable models)
and PMA was evaluated using the correlation coefficient
(Pearson’s). The bias, variance, and absolute error
between predicted age and PMA were also used as mea-
sures of goodness-of-fit.10 The use of repeated (serial)
measures allowed the application of a linear mixed effects
model (LMM) where the model output was a fixed effect
and the infant ID was a random effect. The adjusted r
value was used to assess the goodness-of-fit taking into
account multiple recordings from each infant. Statistical
comparisons of measures of the goodness-of-fit between
EEG metrics for the prediction of PMA were performed
using resampling methods (bootstrap). A correlation coef-
ficient was deemed significantly different if the 95% confi-
dence interval of differences (estimated via a bootstrap)
did not span zero, that is, was either entirely positive or
negative. Differences in prediction accuracy (absolute
error) between the Vienna (training) and Utrecht (valida-
tion) sets were evaluated using equivalence testing with a
two, one-sided t-tests (TOST) procedure based on
Welch’s t-test.29 We used a mean difference in absolute
error of 0.5 weeks as a conservative equivalence bound-
ary based on the results of previous work which reported
an absolute prediction error of approximately 1 week.11
Differences in FBA trajectories (FBA subtracted from
PMA averaged across all recordings per infant) between
outcome groups were tested using a one-way ANOVA,
with Levene’s test for homogeneity of group variances
and a post hoc analysis performed using Tukey’s Range
test to correct for multiple comparisons. FBA trajectories
in each group were assessed to determine if they were sig-
nificantly different from zero using a t-test. For post-hoc
analyses, Cohen’s D statistic, with small sample size cor-
rection, was used to estimate the effect size between
groups. All tests were two-sided and used a level of signif-
icance of 0.05.
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Results
PMA prediction using a single variable FBA
Across all metrics tested, the qEEG variable that had the
highest correlation with PMA was the asymmetry of aver-
age burst shape (Fig. 2A), which exhibits a strong linear
relationship with bursts becoming more symmetric with
increasing PMA (Fig. 2B). Several additional qEEG vari-
ables were strongly associated with PMA (Table S1 in the
Supporting Information). Metrics that were not reliably
predictive of PMA were varied in nature and included
several relative band powers and measures of burst dura-
tion.
PMA prediction using the multivariable FBA
Combining several qEEG variables into a multivariable
model improved the prediction accuracy of the FBA
(Table 2). Assessed within a leave-one-out cross-valida-
tion, the multivariable FBA model had a significantly
higher correlation with PMA than a single variable model
based on the single best variable (asymmetry of the burst
shape) for models based on bursts, phenomenological, and
other newly proposed qEEG variables (Dr = 0.109, 95%
CI: 0.059 to 0.162; Dr = 0.095, 95% CI: 0.045 to 0.150;
Dr = 0.094, 95% CI: 0.057 to 0.142; n = 177, respectively).
The multivariable model using qEEG variables derived
from only burst analysis had a significantly higher correla-
tion with PMA than multivariable models based on phe-
nomenological or other newly proposed qEEG variables
(Dr = 0.030, 95% CI: 0.001 to 0.062; Dr = 0.027, 95% CI:
0.005 to 0.049; n = 177, respectively).
Incorporating qEEG variables into a multivariable
model, via a variable selection procedure, further improved
the accuracy of the FBA (Table 2). The FBA estimator
identified PMA to within 2 weeks for 90% of recordings,
with a median absolute error of 0.7 weeks. A scatter plot
of FBA versus PMA exhibits a clear linear trend (Fig. 3A),
with a tight clustering of FBA within 2 weeks of the
PMA. The performance of this FBA, which contained a
mixture of burst, phenomenological, and other recently
developed EEG variables, was significantly higher than
multivariable models based on only phenomenological
analysis, burst analysis or other analyses alone (Dr = 0.045,
95% CI: 0.020 to 0.073; Dr = 0.015, 95% CI: 0.002 to
0.028; and Dr = 0.042, 95% CI: 0.024 to 0.063, respec-
tively; n = 177). Variable selection resulted in a median of
53 variables (IQR; 49–55; n = 65 folds, see Table S1 in the
Supporting Information for more details).
Validation of FBA on an independent
dataset
To directly address the generalizability of our results, we
validated the multivariable model on an independent
dataset. We found that the multivariable model trained
on Vienna data (evaluated via cross-validation) and
applied to the Utrecht dataset performs near physiological
limits in prediction accuracy, with 90% of epochs cor-
rectly identified to within 2 weeks (Table 2). The abso-
lute error between the FBA and PMA, when applied to
the Utrecht data, was equivalent to the cross-validation
results from the Vienna dataset across a similar range of
PMA (Fig. 3B: P < 0.001; TOST, equivalence boundary of
0.5 weeks). Training with centro-temporal recordings
Figure 2. Changes in burst characteristics with post-menstrual age (PMA). (A) Asymmetry of average burst shape versus PMA (r is Pearson’s
linear correlation coefficient). (B) Average burst shape of the EEG amplitude grouped according to PMA with fortnightly steps from 25 weeks; the
inset shows the entire average burst. The changes seen in (B) are best represented by measures of burst asymmetry.
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also resulted in a FBA that was strongly correlated with
PMA when applied to the Utrecht dataset (Table 2).
FBA for tracking individual growth and
predicting neurodevelopmental outcomes
The accuracy of FBA in tracking cot-side development
raises the idea that FBA may be useful for individualized
assessment of functional maturity. We used linear mixed
modelling to account for serial recordings from individual
infants which resulted in an adjusted correlation of
r = 0.978 (95% CI: 0.974–0.987; n = 65). The improve-
ment in correlation over a point-wise estimate implies
that individual infant trajectories are more highly corre-
lated with PMA than the cohort average. In other words,
infants tend to follow their individual growth trajectories
(Fig. 4A), and the FBA is able to track these trajectories
with high accuracy. In a subgroup of infants with more
Table 2. The performance of several multivariable FBA models for predicting PMA in preterm infants on training (cross-validation) and validation
datasets.
r [95% CI] Bias (weeks)
Variance
(weeks)
Absolute difference
(weeks) [IQR] 1 week (%) 2 weeks (%)
Phenomenological
(n = 177; m = 46)
0.894 [0.859–0.919] 0.1 2.1 0.9 [0.4–1.6] 55 83
Other
(n = 177; m = 10)
0.896 [0.866–0.920] 0.1 2.1 0.9 [0.5–1.5] 53 84
Bursts
(n = 177; m = 40)
0.923 [0.905–0.940] 0.2 1.6 0.9 [0.3–1.4] 60 89
Variable Selection
(n = 177; m = 53)
0.938 [0.922–0.952] 0.1 1.3 0.7 [0.4–1.3] 63 90
Validation: Vienna
(n = 134; m = 53)
0.900 [0.873–0.929] 0.2 1.1 0.6 [0.3–1.2] 64 92
Validation: Utrecht
(FC: n = 99; m = 53)
0.765 [0.665–0.846] 0.1 1.5 0.9 [0.4–1.3] 61 90
Validation: Utrecht
(CO: n = 99;
m = 53)
0.674 [0.554–0.758] 0.3 2.0 1.0 [0.4–1.6] 53 80
r is the correlation coefficient, n is the number of recordings included in analysis, m is the number of qEEG variables used in the model (for vari-
able selection this is the median number across folds of the cross-validation), 95% CI is the 95th percentile of the confidence interval, IQR is inter-
quartile range, FC and CO denote a FBA trained on fronto-central and centro-occipital derivations, respectively.
Figure 3. The correlation between a multivariable FBA and PMA. (A) The multivariable FBA, with variable selection, evaluated on the Vienna
dataset via leave-one-subject-out cross-validation over the full range of EEG recording PMAs (24–38 weeks). (B) The multivariable FBA trained on
the Vienna dataset and applied to an independent dataset recorded from Utrecht over the full range of EEG recording PMAs from the Utrecht
dataset (24–34 weeks). Dashed lines denote 2 weeks difference between FBA and PMA.
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than two serial recordings (a median PMA range of
6.2 weeks, IQR: 4.6 to 7.5 weeks; Fig. 4B), the average
predicted age difference (PAD: difference between FBA
and PMA) was significantly associated with neurodevelop-
mental outcome (One-way ANOVA: F statistic = 3.980,
df = 2, P = 0.029; n = 35, 3 groups: normal, mildly
abnormal, abnormal – see Fig. 4C; group variances were
homogenous; Levene’s Test: P = 0.82). Infants with
abnormal outcome (n = 9) had a PAD that was signifi-
cantly less than infants with mildly abnormal outcome
(n = 13) (Cohen’s D = 1.12, P = 0.025, corrected for
multiple comparisons using Tukey’s Range Test). The
estimated PAD in these infants was also significantly
below 0 weeks (t-test: Cohen’s D = 0.661, P = 0.035;
n = 9) suggesting a persistent delay in brain maturation
(i.e., negative PAD) in infants with abnormal outcome.
These differences were not apparent when including
infants with less than three serial EEG recordings
(ANOVA: F statistic = 0.112, df = 2, P = 0.894; n = 54),
suggesting that multiple recordings may be required to
assess a PAD associated with neurodevelopmental out-
come.
Discussion
The brain matures rapidly in early life with a wide range of
structural and functional indices changing over time spans
as short as a few weeks. Here, we showed that automated
analysis of preterm EEG can be used to track maturation
of cortical function with high accuracy. This analysis con-
verts the EEG into an “age” trend (FBA) that can be con-
sidered as a biomarker of maturity in preterm EEG. This
multivariable prediction of age from the EEG enables the
estimation of functional brain maturity to within 1–
2 weeks of PMA; an accuracy that generalized to an inde-
pendent validation dataset acquired under a considerably
different EEG recording environment. The margin of error
is far lower than similar predictions in preterm infants
based on functional neuroimaging with fMRI and orders
of magnitude lower than what is achieved over later stages
of life using EEG or MRI (error margins of 5–10 years).30-
32 Our findings are also comparable to an array of somatic
anatomical methods over similar preterm age ranges based
on measures of femur length, head circumference, weight,
and structural MRI (cortical folding, thickness).33,34 This
supports the concept of rapid and distinct changes in anat-
omy and physiology throughout the preterm period and
suggests that physiological and anatomical growth are
strongly intertwined.18,35,36
The multivariable model developed here advances previ-
ous work that was designed to capture key visual elements
of EEG review for age prediction. Incorporating burst
measures based on the analysis of crackling noise resulted
in the most accurate single variable model, improved mul-
tivariable model accuracy, and provided a potential frame-
work to explain the mechanistic origins of rapidly evolving
preterm EEG signals. The existence of asymmetric burst
shapes replicates our previous findings in independent
datasets when identifying pathological changes in the EEG
at or near birth.13,17 We also validated several recently pro-
posed qEEG variables of maturation: suppression curve,
mPLI, global ASI, multi-scale entropy, and path length
(coherence) as excellent predictors of age within the pre-
term period. This supports the use of automated measures
of EEG (qEEG) for the extraction of useful information in
addition to visual interpretation.
We also successfully validated the model’s robustness
on unseen data. This showed that the prediction accuracy
of the multivariable model holds when translating to a
dataset collected within a different clinical environment
and with different recording parameters (e.g., amplifier,
electrode type, number, and location). This is a crucial
hurdle for the clinical translation of new methods, which
is impossible to establish in a dataset acquired under uni-
form conditions. Notably, the independent validation
dataset was collected using a 4-channel recording mon-
tage that is commonly used in brain monitoring with the
amplitude integrated EEG.37 This validation on heteroge-
neous data establishes the wider clinical applicability of
determining functional brain age from EEG.
Various measures of growth are commonly used in
health care. The finding that neurological dysfunction
manifests as immaturity in the EEG is intuitively appeal-
ing, and indeed, has been a cornerstone of clinical EEG
review for decades.5,38,39 This hypothesis can only be
accurately tested with measures that are strongly corre-
lated with age. We show that most phenomenological
measures used in clinical EEG research, such as inter-
burst interval, EEG amplitude, or spectral power, are only
weakly correlated with age, which challenges their applica-
bility for maturational EEG assessment. More recently
proposed qEEG measures (such as asymmetry and sharp-
ness of burst shape, suppression curve, mPLI, MSE, and
path length) and multivariable models of age are strongly
correlated with PMA and, therefore, more relevant for
maturational analyses.
We show that infants follow individual functional mat-
uration trajectories in a highly predictable manner. Analy-
sis of these trajectories with measures such as PAD (the
difference between FBA and PMA) can, potentially, be
used to predict neurodevelopmental outcome. This sug-
gests that early neurological adversities become embedded
in cortical function (EEG recordings).40 The potential of
PAD measures was only apparent in infants with multiple
recordings over a wide range of PMA within the preterm
period. Summarizing across multiple recordings resulted
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in a PAD that was able to capture both acute and chronic
delays in functional maturation.5
Limited sample sizes, a reality when studying critically
ill infants, mean that the reported links between PAD and
outcome cannot take into account the variety of factors
that may confound this result such as physiological chal-
lenges, routine cares, and interventions experienced by
preterm infants during their stay in intensive care. These
factors will also confound the FBA and include the
difference between GA and PMA (intra-uterine vs extra-
uterine maturation), postnatal adaption, medications,
ventilation, birthweight, kangaroo care/infant massage,
and gender.41-46 We aim to investigate these effects in
future work to differentiate them from other potential
causes of inter-subject variability such as natural variabil-
ity in the course of in-utero growth.47 Nevertheless, FBA
provides an accurate prediction of PMA even when based
on a small training sample with an array of potentially
Figure 4. Functional brain age prediction using a multivariable model of quantitative EEG measures. (A) Maturational trajectories of individual
infants, with at least two serial recordings per infant; n = 54, colored according to the average differences between FBA and PMA (PAD:
predicted age difference) in each infant. The color bar denotes the PAD in weeks. (B) Scatter plot of the subgroup of data, with at least three
serial recordings, used to evaluate the prediction error for outcome prediction; n = 35, colored according to neurodevelopmental outcome.
Straight dashed lines denote a difference of plus or minus 2 weeks between PMA and predicted age. (C) Subgroup analysis of EEG predicted age
minus PMA with respect to outcome was graded as N – normal (minimum Bayley’s score> 85), M – mildly abnormal (minimum Bayley’s score
between 70 and 85) and A – abnormal (minimum Bayley’s score < 70). The asterisks denote P < 0.05 between outcome groups and when
testing each outcome group against a null hypothesis of zero mean EEG maturity. Data points in (C) have been shifted horizontally for clarity of
presentation and are denoted with filled circles. Data points in (C) represented by triangles are infants with intra-ventricular hemorrhage.
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confounding factors that were not explicitly modelled.
This is a reassuring finding, but the incorporation of EEG
trends such as FBA into routine clinical practice requires
an FBA trained on larger cohorts and further validation
using other well characterized clinical cohorts to tease out
the role of potential confounders, and determine the
effect of acute, chronic or even longer-term changes in
the underlying EEG.
The clinical potential of FBA is twofold. First, the track-
ing of individual growth trajectories is becoming an impor-
tant part of individualized medicine for preterm
infants.48,49 Tracking FBA provides a crucial functional
complement to anatomical growth charts, being sensitive to
the functional consequence of perinatal adversities specific
to early neurological development. Second, these analyses
may have an important role in clinical trials, as recent pro-
gress in early therapeutic interventions has been hampered
by delays due to the assessment of outcome several years
after birth. The use of very early measures of neurodevelop-
ment, like FBA, could lead to dramatically expedited study
cycles by allowing more dynamic, adaptive study designs
with optimized sample sizes and research questions.50 The
estimation of FBA also has clear applications in develop-
mental neuroscience, where the assessment of maturation
based on cortical function can be used to benchmark mod-
els of early human neurological development across species
and within human brain organoids.51,52
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